FDA — authorised 16 October 1984
- Marketing authorisation holder: FRESENIUS KABI USA
- Status: approved
FDA authorised Pentam on 16 October 1984
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 16 October 1984; FDA authorised it on 16 October 1984.
FRESENIUS KABI USA holds the US marketing authorisation.